CCXIU — Churchill Capital XI Share News
0.000.00%
Last trade - 00:00- $632.20m
- $630.94m
Brief: ChemoCentryx Reports Results from Ongoing Trial of CCX559 at AACR Annual Meeting 2022
U.S. RESEARCH ROUNDUP- Gohealth, Hewlett Packard Enterprise, Sofi Technologies
U.S. STOCKS ON THE MOVE-Hewlett Packard, Pfizer, coal stocks
ChemoCentryx Inc reports results for the quarter ended in December - Earnings Summary
ChemoCentryx Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: ChemoCentryx Announces EU Approval Of Tavneos (Avacopan) For The Treatment Of Anca-Associated Vasculitis
U.S. RESEARCH ROUNDUP- Bank of America, Everbridge, Synopsys
ChemoCentryx up as European drug panel backs rare autoimmune disease drug
Brief: ChemoCentryx Says EMA Committee Gives Positive Recommendation For Use Of Tavneos In ANCA Vasculitis
ChemoCentryx Inc reports results for the quarter ended in September - Earnings Summary
Brief: ChemoCentryx Reports Qtrly Loss Per Share $0.32
U.S. RESEARCH ROUNDUP-Beacon Roofing Supply, Moderna, Summit Materials
Brief: ChemoCentryx Inc Appoints Rita I. Jain, M.D. As Executive Vice President, Chief Medical Officer
U.S. RESEARCH ROUNDUP- Chemocentryx, Dutch Bros, Netflix
Refinitiv Newscasts - Trading At Noon: Wall Street subdued after September jobs miss
U.S. STOCKS ON THE MOVE-ChemoCentryx, Biogen, Conagra, Immuron, Owlet
ChemoCentryx leads premarket gainers after FDA approves drug
U.S. STOCKS ON THE MOVE-Oatly, Sundial Growers, Oscar Health, Allogene Therapeutics
NASDAQ RESUMED AT 07:30 AM